{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/71336-1002#drug","name":"OXLUMO","alternateName":"lumasiran","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"71336-1002"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA214103"},{"@type":"PropertyValue","propertyID":"UNII","value":"67P6XH37HD"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"16985a31-f5e4-4557-9266-fc78d4bc5055"}],"activeIngredient":"LUMASIRAN SODIUM","administrationRoute":["SUBCUTANEOUS"],"dosageForm":"INJECTION, SOLUTION","manufacturer":{"@type":"Organization","name":"Alnylam Pharmaceuticals, Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA214103","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=16985a31-f5e4-4557-9266-fc78d4bc5055","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71336-1002"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-04T00:37:06.942Z"}}